In a non-randomised, propensity-matched comparison of intermediate-risk severe aortic stenosis patients (783 per group), 10-year mortality was 83.4% after SAPIEN 3 TAVR vs 82.3% after surgery (HR 1.01; P=0.82); reintervention 2.0% vs 1.9%.
RCTn = 2,005
Nazif et al. 10-Year Outcomes of SAPIEN 3 Transcatheter Aortic Valve Replacement or Surgery in Intermediate-Risk Patients